Old versus new: weighing the evidence between the firstand second-generation antipsychotics

被引:22
|
作者
Davis, JM [1 ]
Chen, N [1 ]
机构
[1] Univ Illinois, Univ Maryland Psychiat Res Ctr, Dept Psychiat, Chicago, IL 60680 USA
关键词
antipsychotics; meta-analysis; efficacy; dose;
D O I
10.1016/j.eurpsy.2004.11.002
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
In our opinion the best guide to prescribing antipsychotics is the clinician's experience with his patients and in particular the patient being treated. If treatment works. stick with it. We feel it is also important for the clinician to consider the evidence front well-controlled double-blind random-assignment studies because in "evidence-based medicine," biases both known and unknown are controlled by blinding, and randomization. The purpose of this paper is to summarize and discuss the evidence on efficacy. Choice of antipsychotic. in our opinion. is probably the most important decision that the clinician makes for the psychotic patient. This involves the choice of drug. its dose. balancing efficacy, side-effects and cost. (C) 2004 Published by Elsevier SAS.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 50 条
  • [41] Onset of Action of Selected Second-Generation Antipsychotics (Pines)-A Systematic Review and Meta-Analyses
    Meyer, Rikke
    Skov, Kenneth
    Dhillon, Inderjeet Kaur
    Olsson, Emilie
    Graudal, Niels Albert
    Baandrup, Lone
    Juergens, Gesche
    BIOMEDICINES, 2023, 11 (01)
  • [42] Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management
    Krill, Rebecca A.
    Kumra, Sanjiv
    ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2014, 5 : 171 - 182
  • [43] Adverse Effects of Second-Generation Antipsychotics as Adjuncts to Antidepressants Are the Risks Worth the Benefits?
    Thase, Michael E.
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2016, 39 (03) : 477 - +
  • [44] Second-generation antipsychotics and adiponectin levels in schizophrenia: A comparative meta-analysis
    Bartoli, Francesco
    Crocamo, Cristina
    Clerici, Massimo
    Carra, Giuseppe
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (10) : 1767 - 1774
  • [45] Second-Generation Antipsychotics for the Treatment of Disruptive Behaviour Disorders in Children: A Systematic Review
    Pringsheim, Tamara
    Gorman, Daniel
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2012, 57 (12): : 722 - 727
  • [46] Current and Novel Approaches to Mitigate Cardiometabolic Adverse Effects of Second-Generation Antipsychotics
    Skonieczna-Zydecka, Karolina
    Loniewski, Igor
    Stachowska, Ewa
    Marlicz, Wojciech
    Correll, Christoph U.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2020, 23 (08) : 491 - 495
  • [47] Combination Therapy of Long-Acting Injectable Second-Generation Antipsychotics and Oral Antipsychotics A Retrospective Chart Review and Prescribers' Attitude Survey
    Misawa, Fuminari
    Amemiya, Ami
    Fujii, Yasuo
    Takeuchi, Hiroyoshi
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (01) : 81 - 86
  • [48] Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders
    Steen, Nils Eiel
    Aas, Monica
    Simonsen, Carmen
    Dieset, Ingrid
    Tesli, Martin
    Nerhus, Mari
    Gardsjord, Erlend
    Morch, Ragni
    Agartz, Ingrid
    Melle, Ingrid
    Ueland, Torill
    Spigset, Olav
    Andreassen, Ole A.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2017, 18 (06) : 471 - 482
  • [49] Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics
    Gutwinski, Stefan
    Mueller, Peter
    Koller, Manfred
    PSYCHIATRISCHE PRAXIS, 2007, 34 (06) : 289 - 291
  • [50] A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia
    Taylor, David
    Hayhurst, Karen
    Kerwin, Robert
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (03) : 133 - 136